drugset / Trial / NCT00827112
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a pilot study to examine if the novel treatment regimen maraviroc plus boosted atazanavir can be expected to be safe and efficacious in treatment naive HIV infected patients. Based on the results from this study, a confirmatory phase 3 study may be conducted.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | 150 mg | — |
| Subject | Tenofovir | Small molecule | 300 mg | — |
| Subject | emtricitabine | Other / unclassified | 200 mg | — |
| Background | Atazanavir | Other / unclassified | 300 mg | — |
| Background | Darunavir | Small molecule | 800 mg | — |
| Background | Lopinavir | Other / unclassified | 400 mg | — |
| Background | Ritonavir | Other / unclassified | 100 mg | — |